Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Tumor Angiogenesis Is Differentially Regulated by Phosphorylation of Endothelial Cell Focal Adhesion Kinase Tyrosines-397 and -861.

Pedrosa AR, Bodrug N, Gomez-Escudero J, Carter EP, Reynolds LE, Georgiou PN, Fernandez I, Lees DM, Kostourou V, Alexopoulou AN, Batista S, Tavora B, Serrels B, Parsons M, Iskratsch T, Hodivala-Dilke KM.

Cancer Res. 2019 Sep 1;79(17):4371-4386. doi: 10.1158/0008-5472.CAN-18-3934. Epub 2019 Jun 12.

PMID:
31189647
2.

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.

Fearon AE, Carter EP, Clayton NS, Wilkes EH, Baker AM, Kapitonova E, Bakhouche BA, Tanner Y, Wang J, Gadaleta E, Chelala C, Moore KM, Marshall JF, Chupin J, Schmid P, Jones JL, Lockley M, Cutillas PR, Grose RP.

Cell Rep. 2018 Feb 27;22(9):2469-2481. doi: 10.1016/j.celrep.2018.02.028.

3.

Visualizing Ebolavirus Particles Using Single-Particle Interferometric Reflectance Imaging Sensor (SP-IRIS).

Carter EP, Seymour EÇ, Scherr SM, Daaboul GG, Freedman DS, Selim Ünlü M, Connor JH.

Methods Mol Biol. 2017;1628:259-270. doi: 10.1007/978-1-4939-7116-9_21.

PMID:
28573627
4.

Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment.

Clayton NS, Wilson AS, Laurent EP, Grose RP, Carter EP.

Dev Dyn. 2017 Jul;246(7):493-501. doi: 10.1002/dvdy.24514. Epub 2017 May 18. Review.

5.

A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer.

Carter EP, Gopsill JA, Gomm JJ, Jones JL, Grose RP.

Breast Cancer Res. 2017 Apr 21;19(1):50. doi: 10.1186/s13058-017-0843-4.

6.

Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.

Carter EP, Fearon AE, Grose RP.

Trends Cell Biol. 2015 Apr;25(4):221-33. doi: 10.1016/j.tcb.2014.11.003. Epub 2014 Nov 29. Review.

PMID:
25467007
7.

Stimulation of MAP kinase pathways after maternal IL-1beta exposure induces fetal lung fluid absorption in guinea pigs.

Bhattacharjee R, Li T, Koshy S, Beard LL, Sharma K, Carter EP, Garat C, Folkesson HG.

Respir Res. 2007 Mar 26;8:27.

8.

Endothelin-B receptor overexpression prevents hypoxic pulmonary hypertension in cirrhotic rats.

Imamura M, Vitello AM, Limbird JN, Ivy DD, Fallon MB, Carter EP.

Chest. 2005 Dec;128(6 Suppl):580S-581S. No abstract available.

PMID:
16373843
9.

Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation.

Imamura M, Luo B, Limbird J, Vitello A, Oka M, Ivy DD, McMurtry IF, Garat CV, Fallon MB, Carter EP.

J Appl Physiol (1985). 2005 Feb;98(2):739-47. Epub 2004 Oct 29.

10.

Continual emerging roles of HO-1: protection against airway inflammation.

Carter EP, Garat C, Imamura M.

Am J Physiol Lung Cell Mol Physiol. 2004 Jul;287(1):L24-5. Review. No abstract available.

11.

Increased epoxyeicosatrienoic acid formation in the rat kidney during liver cirrhosis.

Miyazono M, Zhu D, Nemenoff R, Jacobs ER, Carter EP.

J Am Soc Nephrol. 2003 Jul;14(7):1766-75.

12.

EDHF-mediated vasodilation involves different mechanisms in normotensive and hypertensive rat lungs.

Morio Y, Carter EP, Oka M, McMurtry IF.

Am J Physiol Heart Circ Physiol. 2003 May;284(5):H1762-70. Epub 2003 Jan 9.

13.

Decreased renal heme oxygenase-1 expression contributes to decreased renal function during cirrhosis.

Miyazono M, Garat C, Morris KG Jr, Carter EP.

Am J Physiol Renal Physiol. 2002 Nov;283(5):F1123-31.

14.

Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome.

Carter EP, Hartsfield CL, Miyazono M, Jakkula M, Morris KG Jr, McMurtry IF.

Am J Physiol Lung Cell Mol Physiol. 2002 Aug;283(2):L346-53.

15.

Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy.

Cadnapaphornchai MA, Ohara M, Morris KG Jr, Knotek M, Rogachev B, Ladtkow T, Carter EP, Schrier RW.

Am J Physiol Renal Physiol. 2001 Apr;280(4):F592-8.

16.

Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis.

Xu L, Carter EP, Ohara M, Martin PY, Rogachev B, Morris K, Cadnapaphornchai M, Knotek M, Schrier RW.

Am J Physiol Renal Physiol. 2000 Dec;279(6):F1110-5.

17.

Inhibition of K(Ca) channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis.

Carter EP, Sato K, Morio Y, McMurtry IF.

Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L903-10.

18.

New in situ mouse model to quantify alveolar epithelial fluid clearance.

Garat C, Carter EP, Matthay MA.

J Appl Physiol (1985). 1998 May;84(5):1763-7.

19.

Highly water-permeable type I alveolar epithelial cells confer high water permeability between the airspace and vasculature in rat lung.

Dobbs LG, Gonzalez R, Matthay MA, Carter EP, Allen L, Verkman AS.

Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2991-6.

20.
21.

Perfusion technique determines alveolar fluid resorption rate in the isolated perfused rat lung.

Lasnier JM, Ingbar DH, Carter EP, Wilson K, McKnite S, Lurie KG, Wangensteen OD.

J Appl Physiol (1985). 1998 Feb;84(2):740-5.

22.

Hyperoxic effects on alveolar sodium resorption and lung Na-K-ATPase.

Carter EP, Wangensteen OD, Dunitz J, Ingbar DH.

Am J Physiol. 1997 Dec;273(6):L1191-202. doi: 10.1152/ajplung.1997.273.6.L1191.

PMID:
9435574
23.

Developmental changes in water permeability across the alveolar barrier in perinatal rabbit lung.

Carter EP, Umenishi F, Matthay MA, Verkman AS.

J Clin Invest. 1997 Sep 1;100(5):1071-8.

24.

Effects of hyperoxia on type II cell Na-K-ATPase function and expression.

Carter EP, Wangensteen OD, O'Grady SM, Ingbar DH.

Am J Physiol. 1997 Mar;272(3 Pt 1):L542-51.

PMID:
9124612
25.

Sharp increase in rat lung water channel expression in the perinatal period.

Umenishi F, Carter EP, Yang B, Oliver B, Matthay MA, Verkman AS.

Am J Respir Cell Mol Biol. 1996 Nov;15(5):673-9.

PMID:
8918374
26.
27.

Hyperoxia increases active alveolar Na+ resorption in vivo and type II cell Na,K-ATPase in vitro.

Carter EP, Duvick SE, Wendt CH, Dunitz J, Nici L, Wangensteen OD, Ingbar DH.

Chest. 1994 Mar;105(3 Suppl):75S-78S. No abstract available.

PMID:
8131618
28.

Isolated ACTH deficiency with absent response to corticotrophin-releasing factor--41. Evidence for a primary pituitary defect.

Murch SH, Carter EP, Tsagarakis S, Grossman A, Savage MO.

Acta Paediatr Scand. 1991 Feb;80(2):259-61.

PMID:
1852085
29.

Thyroid function in children after treatment for acute lymphoblastic leukaemia.

Carter EP, Leiper AD, Chessells JM, Hurst A.

Arch Dis Child. 1989 Apr;64(4):631. No abstract available.

30.

Familial salivary gland insensitivity to aldosterone: a variant of pseudohypoaldosteronism.

Sanderson IR, Carter EP, Dillon MJ, Oberholzer VG, Savage MO.

Horm Res. 1989;32(4):145-7.

PMID:
2625324
31.
32.

Improved sweat test method for the diagnosis of cystic fibrosis.

Carter EP, Barrett AD, Heeley AF, Kuzemko JA.

Arch Dis Child. 1984 Oct;59(10):919-22.

33.

THE REFRACTORY PERIOD OF THE NORMALLY-BEATING DOG'S AURICLE; WITH A NOTE ON THE OCCURRENCE OF AURICULAR FIBRILLATION FOLLOWING A SINGLE STIMULUS.

Andrus EC, Carter EP; With an Appendix by Harold A. Wheeler, Ph.D.

J Exp Med. 1930 Feb 28;51(3):357-67.

34.

THE MECHANISM OF THE ACTION OF THE HYDROGEN ION UPON THE CARDIAC RHYTHM.

Andrus EC, Carter EP.

J Clin Invest. 1927 Feb;3(3):555-64. No abstract available.

35.

Clinical Experience with Powdered Leaves of Digitalis.

Andrus EC, Carter EP.

Proc R Soc Med. 1924;17(Ther Pharmacol Sect):26-8. No abstract available.

36.

THE GENESIS OF NORMAL AND ABNORMAL CARDIAC RHYTHM.

Andrus EC, Carter EP.

Science. 1923 Nov 9;58(1506):376-9. No abstract available.

PMID:
17837333

Supplemental Content

Loading ...
Support Center